Lukas Scherer

Lukas Scherer serves as Chief Technology Officer at GlucoSet. GlucoSet operates in the medical devices sector with approximately 21.0 employees. The company is headquartered in Lucerne, Lucerne. To date, GlucoSet has raised 9453907.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 59 executive contacts are available in Lucerne.
• • Our database includes 201,468 c suite-level executives.

Gmail Google Apps Google Tag Manager Vimeo Google Analytics Typekit Splunk Basis Circle Domo Remote Sisense KNIME AI

medical equipment manufacturing glucose control continuous monitoring icu minimally invasive patient care blood glucose management cost reduction reduced complications high accuracy real-time monitoring sensor technology critical care insulin therapy hypoglycemia sepsis prevention easy adoption clinical workflow biomarker arterial access patented technology medical device healthcare innovation cost-effective solution clinical research patient outcomes iop protection research funding biomedical engineering sensor development translational medicine diagnostics medical sensors blood glucose sensor dynamic measurement non-invasive monitoring data accuracy risk mitigation intensive care unit artificial intelligence biostatistics harmful extremes long-term care clinical trials health data spectroscopy business development patient safety technology scaling medtech advancement medical devices hospital & health care information technology & services long term care health care health wellness & fitness b2b

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Lukas Scherer in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at GlucoSet.

Lukas Scherer's Position in the MessageCEO Database

• •Lukas Scherer is 1 of 1 verified executive contact we track at GlucoSet.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •59 verified executive contacts in Lucerne are in the database.
• •26 verified contacts work at medical devices companies in the 21.0 employee range (same size as GlucoSet).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Lukas Scherer directly?

Lukas Scherer's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at GlucoSet. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Lukas Scherer work for?

Lukas Scherer is Chief Technology Officer at GlucoSet, a company in the medical devices sector with 21.0 employees. The company is based in Lucerne, Lucerne.

Can I pitch or sell to Lukas Scherer?

As Chief Technology Officer at GlucoSet, Lukas Scherer is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Lukas Scherer directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Lukas Scherer in?

Lukas Scherer works in the medical devices industry as Chief Technology Officer at GlucoSet. MessageCEO provides verified contact information for executives across all major industries.

Is Lukas Scherer's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Lukas Scherer's profile is kept up-to-date with the latest available information.

Last updated: July 25, 2026